مقالة · مجلة · 2016

A Triazolopyrimidine-Based Dihydroorotate Dehydrogenase Inhibitor with Improved Drug-like Properties for Treatment and Prevention of Malaria

ACS Infectious Diseases

المؤلفون

36 مؤلفًا من 15 مؤسسة في 9 دول

Argonne National Laboratory
Biological and Environmental Research
Division of Intramural Research, National Institute of Allergy and Infectious Diseases
Medicines for Malaria Venture
National Institute of Allergy and Infectious Diseases
National Institutes of Health
U.S. Department of Energy
University of Chicago
Welch Foundation
Wellcome Trust

قد يقع العمل في عدة مجالات، لكلٍّ منها درجة